1. Home
  2. DGHI vs APLT Comparison

DGHI vs APLT Comparison

Compare DGHI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • APLT
  • Stock Information
  • Founded
  • DGHI 2017
  • APLT 2016
  • Country
  • DGHI United States
  • APLT United States
  • Employees
  • DGHI N/A
  • APLT N/A
  • Industry
  • DGHI Finance: Consumer Services
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGHI Finance
  • APLT Health Care
  • Exchange
  • DGHI Nasdaq
  • APLT Nasdaq
  • Market Cap
  • DGHI 90.1M
  • APLT 80.3M
  • IPO Year
  • DGHI N/A
  • APLT 2019
  • Fundamental
  • Price
  • DGHI $3.07
  • APLT $0.61
  • Analyst Decision
  • DGHI Strong Buy
  • APLT Buy
  • Analyst Count
  • DGHI 1
  • APLT 7
  • Target Price
  • DGHI $2.50
  • APLT $6.10
  • AVG Volume (30 Days)
  • DGHI 874.7K
  • APLT 4.2M
  • Earning Date
  • DGHI 04-02-2025
  • APLT 03-05-2025
  • Dividend Yield
  • DGHI N/A
  • APLT N/A
  • EPS Growth
  • DGHI N/A
  • APLT N/A
  • EPS
  • DGHI N/A
  • APLT N/A
  • Revenue
  • DGHI $42,146,057.00
  • APLT N/A
  • Revenue This Year
  • DGHI N/A
  • APLT N/A
  • Revenue Next Year
  • DGHI N/A
  • APLT $2,622.90
  • P/E Ratio
  • DGHI N/A
  • APLT N/A
  • Revenue Growth
  • DGHI 100.56
  • APLT N/A
  • 52 Week Low
  • DGHI $0.84
  • APLT $0.54
  • 52 Week High
  • DGHI $3.77
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 59.08
  • APLT 27.17
  • Support Level
  • DGHI $2.81
  • APLT $0.54
  • Resistance Level
  • DGHI $3.35
  • APLT $0.66
  • Average True Range (ATR)
  • DGHI 0.49
  • APLT 0.06
  • MACD
  • DGHI -0.01
  • APLT 0.11
  • Stochastic Oscillator
  • DGHI 43.36
  • APLT 40.99

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: